People on Ozempic and Wegovy are increasingly using supplements to handle side effects and nutrition gaps, prompting calls for tighter oversight.
Recap by typeshit. Post by @AlMajallaEN on X.
Both suppliers of compounded semaglutide and tirzepatide ingredients landed on the FDA import-alert list. Times Now also covers dosing mistakes with compounded vials.
Penn researchers stress the self-reports in JAMA Network Open don't prove the drug caused anything, but increased appetite topped the list despite trials pointing to nausea.
The visits came in the country's largest healthcare system, with the trend credited to wellness influencers and young people among those affected.
Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.
The analysis notes the women-only result is post hoc and that women also lose more on tirzepatide, framing Novo's move as a play for OB-GYN prescribers.
She says certain foods prompt the gut to release GLP1 and PYY, which she credits with fullness and slower digestion. A recipe post, not drug news.
Loading…